http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102846639-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f06bcbe83933d1d1550cfe17c011232 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A47K10-16 |
| filingDate | 2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02709eeff9906e9cfaa5116abfb13063 |
| publicationDate | 2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102846639-B |
| titleOfInvention | External application drug liquid wet tissue for treating acne |
| abstract | The present invention relates to a wet tissue, specifically to an external application drug liquid wet tissue for treating acne. The external application drug liquid wet tissue comprises a wet tissue carrier, wherein the wet tissue carrier is sprayed with a drug liquid, and the drug liquid is characterized in that 100 ml of 70-75% ethanol contains 2-5 g of chloroamphenicol powder, 1-2 g of acetylsalicylic acid powder, 5-10 ml of glycerol, and 0.015-0.03 g of nitrofurazone. The external application drug liquid wet tissue of the present invention has characteristics of definite therapeutic effect, less side effects, low production cost, and easy use. |
| priorityDate | 2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.